文献速递关节外科

多种微生物假体周围关节感染:治疗结果与危险因素识别

Polymicrobial Periprosthetic Joint Infections: Outcome of Treatment and Identification of Risk Factors.
PubMed 文献 · J Bone Joint Surg Am · 2016-01-01

单中心2000至2014年共1045例假体周围关节感染中多种微生物感染占10.3%(108/1045),95例随访至少12个月。多种微生物感染失败率50.5%(48/95),高于单微生物的31.5%(63/200)和培养阴性的30.2%(48/159)(p=0.003)。多因素分析仅窦道为独立危险因素(OR 2.20,95%CI 1.39至3.47;p=0.001)。

要点

  • 多种微生物假体周围关节感染占全部假体周围关节感染的10.3%(108/1045)。
  • 多种微生物组失败率50.5%(48/95),高于单微生物组31.5%(63/200)和培养阴性组30.2%(48/159),p=0.003。
  • 多因素分析仅窦道是多种微生物假体周围关节感染的显著危险因素(OR 2.20,95%CI 1.39至3.47;p=0.001)。

核心结论

  • 多种微生物假体周围关节感染发生率相对较低,但与单微生物和培养阴性假体周围关节感染相比治疗结果更差。
  • 多种微生物感染患者更可能需要补救性手术或发生假体周围关节感染相关死亡。
  • 多种微生物假体周围关节感染与窦道等软组织缺损及特定类型微生物相关,在对此类患者使用抗生素时应予以考虑。

研究设计与样本

  • 单中心比较研究,纳入2000至2014年治疗的多种微生物、单微生物或培养阴性假体周围关节感染患者。
  • 95例多种微生物假体周围关节感染患者随访至少12个月,采用倾向性评分匹配与其他队列比较。
  • 治疗成功按Delphi标准定义,并生成Kaplan-Meier生存曲线;采用多元logistic回归分析多种微生物假体周围关节感染的危险因素。

主要发现

  • 本机构治疗的假体周围关节感染中10.3%(108/1045)为多种微生物感染。
  • 多种微生物组失败率50.5%(48/95),单微生物组31.5%(63/200),培养阴性组30.2%(48/159),p=0.003。
  • 多种微生物组生存率2年随访52.2%、5年随访49.3%、10年随访46.8%。
  • 与单微生物假体周围关节感染相比,多种微生物组截肢OR 3.80(95%CI 1.34至10.80)、关节融合OR 11.06(95%CI 1.27至96.00)、假体周围关节感染相关死亡OR 7.88(95%CI 1.60至38.67)。
  • 革兰阴性菌(p<0.01)、肠球菌(p<0.01)、大肠埃希菌(p<0.01)和非典型微生物(p<0.01)的分离与多种微生物假体周围关节感染相关。

关键数值与推荐

  • 治疗成功按Delphi标准定义。
  • 多因素分析中仅窦道为多种微生物假体周围关节感染的显著危险因素(OR 2.20,95%CI 1.39至3.47;p=0.001)。
  • 证据等级:预后Level III。

临床怎么用

  • 作者认为,多种微生物假体周围关节感染与窦道等软组织缺损及特定类型微生物相关,在对此类患者使用抗生素时应予以考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The treatment outcomes of periprosthetic joint infection are frequently dependent on characteristics of the causative organism. The objective of this comparative study was to investigate the prevalence of and risk factors for development of polymicrobial periprosthetic joint infection, and the outcome of surgical treatment of these patients. METHODS: All patients with polymicrobial, monomicrobial, or culture-negative periprosthetic joint infection treated from 2000 to 2014 were identified at a single institution. Ninety-five patients with a polymicrobial periprosthetic joint infection had a minimum follow-up of 12 months. We matched patients with a polymicrobial periprosthetic joint infection with the other cohorts using propensity score matching for several important parameters. Treatment success was defined according to the Delphi criteria; Kaplan-Meier survivorship curves were generated to demonstrate this. A multiple logistic regression analysis was performed to determine risk factors for a polymicrobial periprosthetic joint infection. RESULTS: Overall, 10.3% (108 of 1,045) of the periprosthetic joint infections treated at our institution were polymicrobial in nature. Patients with a polymicrobial periprosthetic joint infection had a higher failure rate at 50.5% (48 of 95) compared with the monomicrobial periprosthetic joint infection cohort at 31.5% (63 of 200) and the culture-negative periprosthetic joint infection cohort at 30.2% (48 of 159) (p = 0.003). The survivorship of the polymicrobial periprosthetic joint infection group was 52.2% at the 2-year follow-up, 49.3% at the 5-year follow-up, and 46.8% at the 10-year follow-up. Patients with polymicrobial periprosthetic joint infection had a higher rate of amputation (odds ratio [OR], 3.80 [95% confidence interval (CI), 1.34 to 10.80]), arthrodesis (OR, 11.06 [95% CI, 1.27 to 96.00]), and periprosthetic joint infection-related mortality (OR, 7.88 [95% CI, 1.60 to 38.67]) compared with patients with monomicrobial periprosthetic joint infection. Isolation of gram-negative organisms (p < 0.01), enterococci (p < 0.01), Escherichia coli (p < 0.01), and atypical organisms (p < 0.01) was associated with polymicrobial periprosthetic joint infection. Only the presence of a sinus tract (OR, 2.20 [95% CI, 1.39 to 3.47]; p = 0.001) was a significant risk factor for polymicrobial periprosthetic joint infection on multivariate analysis. CONCLUSIONS: This study reveals that polymicrobial periprosthetic joint infection, occurring at a relatively low rate, is associated with poor outcomes when compared with monomicrobial and culture-negative periprosthetic joint infection. Patients with polymicrobial infections were more likely to require a salvage procedure or to have periprosthetic joint infection-related mortality. Polymicrobial periprosthetic joint infection was associated with soft-tissue defects such as a sinus tract and certain types of organisms, which should be considered when administering antibiotics to these patients. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Tan TL, Kheir MM, Tan DD, et al. Polymicrobial Periprosthetic Joint Infections: Outcome of Treatment and Identification of Risk Factors. J Bone Joint Surg Am. 2016. PMID: 28002371. doi:10.2106/JBJS.15.01450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。